September 18, 2013 | Israeli biotech startup CureTech, which develops innovative ways to treat cancer, has raised $3.8 million. The finances were raised in a rights issue to majority shareholder Clal.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments